Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors

被引:22
作者
Bowers, Simeon [1 ]
Truong, Anh P. [1 ]
Ye, Michael [1 ]
Aubele, Danielle L. [1 ]
Sealy, Jennifer M. [1 ]
Neitz, R. Jeffrey [1 ]
Hom, Roy K. [1 ]
Chan, Wayman [1 ]
Dappen, Michael S. [1 ]
Galemmo, Robert A., Jr. [1 ]
Konradi, Andrei W. [1 ]
Sham, Hing L. [1 ]
Zhu, Yong L. [2 ]
Beroza, Paul [2 ]
Tonn, George [3 ]
Zhang, Heather [3 ]
Hoffman, Jennifer [3 ]
Motter, Ruth [3 ]
Fauss, Donald [3 ]
Tanaka, Pearl [3 ]
Bova, Michael P. [3 ]
Ren, Zhao [3 ]
Tam, Danny [3 ]
Ruslim, Lany [3 ]
Baker, Jeanne [3 ]
Pandya, Deepal [3 ]
Diep, Linnea [3 ]
Fitzgerald, Kent [3 ]
Artis, Dean R. [3 ]
Anderson, John P. [3 ]
Bergeron, Marcelle [3 ]
机构
[1] Elan Pharmaceut, Dept Chem Sci, San Francisco, CA 94080 USA
[2] Elan Pharmaceut, Dept Mol Design, San Francisco, CA 94080 USA
[3] Elan Pharmaceut, Dept Pharmacol Sci, San Francisco, CA 94080 USA
关键词
Polo like kinase; PLK inhibitor; Parkinson's disease; Alpha-synuclein; ALPHA-SYNUCLEIN; PHOSPHORYLATION;
D O I
10.1016/j.bmcl.2013.02.065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson's disease and this Letter describes the SAR of a series of dihydropteridinone based Plk-2 inhibitors. By optimizing both the N-8 substituent and the biaryl region of the inhibitors we obtained single digit nanomolar compounds such as 37 with excellent selectivity for Plk-2 over Plk-1. When dosed orally in rats, compound 37 demonstrated a 41-45% reduction of pS129-alpha-synuclein levels in the cerebral cortex. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2743 / 2749
页数:7
相关论文
共 16 条
[1]   Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease [J].
Anderson, John P. ;
Walker, Donald E. ;
Goldstein, Jason M. ;
de laat, Rian ;
Banducci, Kelly ;
Caccavello, Russell J. ;
Barbour, Robin ;
Huang, Jiping ;
Kling, Kristin ;
Lee, Michael ;
Diep, Linnea ;
Keim, Pamela S. ;
Shen, Xiaofeng ;
Chataway, Tim ;
Schlossmacher, Michael G. ;
Seubert, Peter ;
Schenk, Dale ;
Sinha, Sukanto ;
Gai, Wei Ping ;
Chilcote, Tamie J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) :29739-29752
[2]  
Aubele D. L., UNPUB
[3]   Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression [J].
de Carcer, Guillermo ;
Escobar, Beatriz ;
Higuero, Alonso M. ;
Garcia, Laura ;
Anson, Alejandra ;
Perez, Gema ;
Mollejo, Manuela ;
Manning, Gerard ;
Melendez, Barbara ;
Abad-Rodriguez, Jose ;
Malumbres, Marcos .
MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (06) :1225-1239
[4]  
Galemmo Jr. R.A., 2011, PCT Int. Appl., Patent No. [WO 2011079118, 2011079118]
[5]  
Galemmo R. A., 2011, WO Patent, Patent No. [WO 2011079114, 2011079114]
[6]   Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System [J].
Inglis, Kelly J. ;
Chereau, David ;
Brigham, Elizabeth F. ;
Chiou, San-San ;
Schoebel, Susanne ;
Frigon, Normand L. ;
Yu, Mei ;
Caccavello, Russell J. ;
Nelson, Seth ;
Motter, Ruth ;
Wright, Sarah ;
Chian, David ;
Santiago, Pamela ;
Soriano, Ferdie ;
Ramos, Carla ;
Powell, Kyle ;
Goldstein, Jason M. ;
Babcock, Michael ;
Yednock, Ted ;
Bard, Frederique ;
Basi, Guriqbal S. ;
Sham, Hing ;
Chilcote, Tamie J. ;
McConlogue, Lisa ;
Griswold-Prenner, Irene ;
Anderson, John P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (05) :2598-2602
[7]   Neuropathology of Lewy body disorders [J].
Koevari, Enikoe ;
Horvath, Judit ;
Bouras, Constantin .
BRAIN RESEARCH BULLETIN, 2009, 80 (4-5) :203-210
[8]   Parkinson's disease [J].
Lees, Andrew J. ;
Hardy, John ;
Revesz, Tamas .
LANCET, 2009, 373 (9680) :2055-2066
[9]   Phosphorylation of Synucleins by Members of the Polo-like Kinase Family [J].
Mbefo, Martial K. ;
Paleologou, Katerina E. ;
Boucharaba, Ahmed ;
Oueslati, Abid ;
Schell, Heinrich ;
Fournier, Margot ;
Olschewski, Diana ;
Yin, Guowei ;
Zweckstetter, Markus ;
Masliah, Eliezer ;
Kahle, Philipp J. ;
Hirling, Harald ;
Lashuel, Hilal A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (04) :2807-2822
[10]  
Neitz R. J., 2012, PCT Int. Appl., Patent No. [WO 2012048129, 2012048129, WO 2012048129A2]